Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2026)

Amneal Pharmaceuticals' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.73 for Q1 2026.

• In Q1 2026, Debt Ratio rose 11.84% year-over-year to 0.73; the TTM figure through Mar 2026 stood at 0.73 (up 11.84% YoY), while the FY2025 annual figure was 0.7, up 2.61% from the prior year.
• Debt Ratio was 0.73 for Q1 2026 at Amneal Pharmaceuticals, up from 0.7 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.74 in Q1 2024 to a low of 0.02 in Q2 2022.
• Historically, Debt Ratio has averaged 0.58 across 5 years, with a median of 0.7 in 2023.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio plunged 97.51% in 2022, then jumped 3995.8% in 2023.
• A 5-year view of Debt Ratio shows it stood at 0.7 in 2022, then slipped by 0.16% to 0.7 in 2023, then dropped by 2.22% to 0.68 in 2024, then rose by 2.61% to 0.7 in 2025, then increased by 3.9% to 0.73 in 2026.
• The last three Debt Ratio figures came in at 0.73 (Q1 2026), 0.7 (Q4 2025), and 0.71 (Q3 2025), per Business Quant data.